Cargando…

In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein

Aptamers are single-stranded, short DNA or RNA oligonucleotides that can specifically bind to various target molecules. To diagnose the infected cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in time, numerous conventional methods are applied for viral detection via the amplif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yu-Chao, Chen, Wen-Yih, Hwu, En-Te, Hu, Wen-Pin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143595/ https://www.ncbi.nlm.nih.gov/pubmed/35628622 http://dx.doi.org/10.3390/ijms23105810

Ejemplares similares

In silico design of quadruplex aptamers against the spike protein of SARS-CoV-2
por: Behbahani, Mandana, et al.
Publicado: (2021)

DNA aptamer selection for SARS-CoV-2 spike glycoprotein detection
por: Martínez-Roque, Mateo Alejandro, et al.
Publicado: (2022)

Designing of peptide aptamer targeting the receptor-binding domain of spike protein of SARS-CoV-2: an in silico study
por: Devi, Arpita, et al.
Publicado: (2021)

In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
por: Ling, Rongsong, et al.
Publicado: (2020)

Binder design for targeting SARS-CoV-2 spike protein: An in silico perspective
por: Etemadi, Ali, et al.
Publicado: (2022)

Aptamer Sandwich Assay for the Detection of SARS-CoV-2 Spike Protein Antigen
por: Svobodova, Marketa, et al.
Publicado: (2021)

Highly Selective Aptamer‐Molecularly Imprinted Polymer Hybrids for Recognition of SARS‐CoV‐2 Spike Protein Variants
por: Sullivan, Mark V., et al.
Publicado: (2023)

In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds
por: Babaeekhou, Laleh, et al.
Publicado: (2021)

DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2
por: Cleri, Fabrizio, et al.
Publicado: (2021)

Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
por: Ramírez-Salinas, Gema Lizbeth, et al.
Publicado: (2020)

In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
por: Maffucci, Irene, et al.
Publicado: (2020)

In Silico Analysis of SARS-CoV-2 Spike Proteins of Different Field Variants
por: Haseeb, Muhammad, et al.
Publicado: (2023)

In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern
por: Rajpoot, Sajjan, et al.
Publicado: (2021)

In Silico Discovery of Small Molecule Modulators Targeting the Achilles’ Heel of SARS-CoV-2 Spike Protein
por: Wang, Qing, et al.
Publicado: (2023)

An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein
por: Ho, Chian, et al.
Publicado: (2023)

Rapid and Efficient Detection of the SARS-CoV-2 Spike Protein Using an Electrochemical Aptamer-Based Sensor
por: Idili, Andrea, et al.
Publicado: (2021)

A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS‐CoV‐2 Variants of Concern
por: Zhang, Zijie, et al.
Publicado: (2022)

Development of high affinity broadly reactive aptamers for spike protein of multiple SARS-CoV-2 variants
por: Le, Thao T., et al.
Publicado: (2023)

In silico selection of RNA aptamers
por: Chushak, Yaroslav, et al.
Publicado: (2009)

Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
por: Jimenez Ruiz, Jose A., et al.
Publicado: (2022)

Combatting future variants of SARS-CoV-2 using an in-silico peptide vaccine approach by targeting the spike protein
por: Biswas, Subhamoy, et al.
Publicado: (2022)

In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2
por: Jain, Anisha S., et al.
Publicado: (2021)

A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2
por: Gupta, Ankit, et al.
Publicado: (2021)

A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism
por: Schmitz, Anton, et al.
Publicado: (2021)

A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism
por: Schmitz, Anton, et al.
Publicado: (2021)

Computational Selection of RNA Aptamer against Angiopoietin-2 and Experimental Evaluation
por: Hu, Wen-Pin, et al.
Publicado: (2015)

Aptamers—Diagnostic and Therapeutic Solution in SARS-CoV-2
por: Wandtke, Tomasz, et al.
Publicado: (2022)

In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy
por: Wei, Tian-zi, et al.
Publicado: (2020)

In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis
por: Harisna, Azza Hanif, et al.
Publicado: (2021)

Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis
por: Rodal Canales, Francisco Javier, et al.
Publicado: (2021)

An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant
por: Shishir, Tushar Ahmed, et al.
Publicado: (2022)

Interaction of Epigallocatechin Gallate and Quercetin with Spike Glycoprotein (S-Glycoprotein) of SARS-CoV-2: In Silico Study
por: Alavi, Mehran, et al.
Publicado: (2022)

Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2
por: Zhang, Zhi-Bi, et al.
Publicado: (2022)

Neutralizing antibodies targeting SARS-CoV-2 spike protein
por: Xiaojie, Shi, et al.
Publicado: (2021)

Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1
por: Yang, Ge, et al.
Publicado: (2021)

Single-molecule studies of RNA aptamers binding to SARS-CoV-2 spike proteins expressed on virus-like particles
por: Israels, Brett, et al.
Publicado: (2023)

On the Selectivity of Heparan Sulfate Recognition by SARS-CoV-2 Spike Glycoprotein
por: Chittum, John E., et al.
Publicado: (2021)

The Spike Protein of SARS-CoV-2 Is Adapting Because of Selective Pressures
por: López-Cortés, Georgina I., et al.
Publicado: (2022)

Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein
por: Chen, Yuliu, et al.
Publicado: (2022)

In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack
por: Hussein, Mouraya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ac42mfk3kqr52vdjlv6revjefg